Male patients with HCV and/or alcoholic related cirrhosis have a higher prevalence of TERT promoter mutations both in tumor tissue and in cfDNA [63], providing the rationale for TERT promoter mutations analysis in cfDNA for early detection in some populations at risk of developing HCC. This evidence concerns the gene TERT and hepatocellular carcinoma.